NasdaqGS:ILMNLife Sciences
How Investors May Respond To Illumina (ILMN) Launching Protein Prep to Advance Multiomics Strategy
Illumina recently announced the global launch of Illumina Protein Prep, a next-generation sequencing-based proteomics assay that enables researchers worldwide to integrate proteomics into large-scale genomics studies with a streamlined solution.
This launch builds on strong early-access validation and marks a significant expansion of Illumina's multiomics platform, supporting initiatives like the UK Biobank collaboration to accelerate discovery in disease research.
We'll examine how the...